At present, some traditional Chinese medicines, such as Qiliqiangxin (QL), were reported to stabilize the gut microbiota after heart failure, inhibiting myocardial fibrosis and cardiac remodeling by reducing the generation of inflammatory factors, such as NLRP3, IL-1B, and TNF-α [92]. The gene discussed is TNF; the disease is heart failure.